Publicacións nas que colabora con Rosana Hernández Antolín (36)

2022

  1. Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396

2021

  1. Percutaneous mitral valve repair: Outcome improvement with operator experience and a second-generation device

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-10

  2. Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

  3. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199

2020

  1. Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair

    Journal of the American College of Cardiology, Vol. 76, Núm. 21, pp. 2463-2473

  2. Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial

    EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921

  3. Transcatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 643-651

2019

  1. Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 154-159

  2. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70

  3. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

    Circulation, Vol. 140, Núm. 23, pp. 1904-1916

2018

  1. First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial

    EuroIntervention

  2. Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

    EuroIntervention, Vol. 14, Núm. 5, pp. e570-e579

  3. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2016

  1. Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)

    American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584

2015

  1. Acceso radial frente a femoral en angioplastia por infarto agudo de miocardio con elevación del segmento ST con stent farmacoactivo de segunda generación

    Revista Espanola de Cardiologia, Vol. 68, Núm. 1, pp. 47-53

  2. Everolimus-eluting stent versus bare-metal stent in elderly (≥ 75 years) versus non-elderly (< 75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the examination trial

    International Journal of Cardiology, Vol. 179, pp. 73-78

  3. Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: Insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials

    EuroIntervention, Vol. 11, Núm. 4, pp. 391-398

2014

  1. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical evaluation of the xience-V stent in acute myocardial INfArcTION) and COMFORTABLE-AMI

    JACC: Cardiovascular Interventions, Vol. 7, Núm. 1, pp. 55-63

  2. Optimization in stent implantation by manual thrombus aspiration in ST-segment-elevation myocardial infarction: Findings from the EXAMINATION trial

    Circulation: Cardiovascular Interventions, Vol. 7, Núm. 3, pp. 294-300

  3. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"

    Circulation